Manuela Pavan
Manuela Pavan has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Arianna Bassan
Innovatune srl, Italy
3 shared publications - Candice Johnson
InStem
2 shared publications - Diane Paskiet
West Pharmaceutical Services
2 shared publications - Douglas Kiehl
Eli Lilly and Company
2 shared publications - Glenn J. Myatt
InStem
2 shared publications - Anders Burild
Novo Nordisk
1 shared publication
Latest Publications
- Open Access
- 7 June 2026
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 171, 106155
Application of read-across to data-poor N-nitrosamines: N-nitroso-ulifloxacin, a case study
- 7 June 2026
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 171, 106155
Open AccessApplication of read-across to data-poor N-nitrosamines: N-nitroso-ulifloxacin, a case study
- 19 December 2023
- Published by Parenteral Drug Association, Inc. in PDA Journal of Pharmaceutical Science and Technology
- Vol. 78 (3) , 214-236
In Silico Assessment of Biomolecule Reactivity with Leachables
Leachables in pharmaceutical products may react with biomolecule Active Pharmaceutical Ingredients (APIs) e.g., mAb, peptide, RNA, potentially compromising product safety, efficacy or impacting quality attributes. This investigation explored a series of in silico models to screen extractables and leachables to assess their possible reactivity with biomolecules. These in silico models were applied to collections of known leachables to identify functional and structural chemical classes likely to be flagged by these in silico approaches. Flagged leachable functional classes included antimicrobials, colorants, and film forming agents, while specific chemical classes, included epoxides, acrylates and quinones. In addition, a dataset of 22 leachables with experimental data indicating their interaction with insulin glargine was used to evaluate whether one or more in silico methods are fit-for-purpose as a preliminary screen for assessing this biomolecule reactivity. Analysis of the data concluded that the sensitivity of an in silico screen using multiple methodologies was 80-90% and specificity 58-92%. A workflow supporting the use of in silico methods in this field is proposed based on both the results from this assessment and best practices in the field of computational modelling and quality risk management.
- 19 December 2023
- Published by Parenteral Drug Association, Inc. in PDA Journal of Pharmaceutical Science and Technology
- Vol. 78 (3) , 214-236
In Silico Assessment of Biomolecule Reactivity with Leachables
Leachables in pharmaceutical products may react with biomolecule Active Pharmaceutical Ingredients (APIs) e.g., mAb, peptide, RNA, potentially compromising product safety, efficacy or impacting quality attributes. This investigation explored a series of in silico models to screen extractables and leachables to assess their possible reactivity with biomolecules. These in silico models were applied to collections of known leachables to identify functional and structural chemical classes likely to be flagged by these in silico approaches. Flagged leachable functional classes included antimicrobials, colorants, and film forming agents, while specific chemical classes, included epoxides, acrylates and quinones. In addition, a dataset of 22 leachables with experimental data indicating their interaction with insulin glargine was used to evaluate whether one or more in silico methods are fit-for-purpose as a preliminary screen for assessing this biomolecule reactivity. Analysis of the data concluded that the sensitivity of an in silico screen using multiple methodologies was 80-90% and specificity 58-92%. A workflow supporting the use of in silico methods in this field is proposed based on both the results from this assessment and best practices in the field of computational modelling and quality risk management.
- 19 December 2023
- Published by Parenteral Drug Association, Inc. in PDA Journal of Pharmaceutical Science and Technology
- Vol. 78 (3) , 237-311
Characterizing Extractables and Leachables Chemical Space to Support In Silico Toxicological Hazard Assessments
This article describes the development of a representative dataset of extractables and leachables (E&L) from the combined Extractables and Leachable Safety Information Exchange (ELSIE) Consortium and the Product Quality Research Institute (PQRI) published datasets, representing a total of 783 chemicals. A chemical structure-based clustering of the combined dataset identified 142 distinct chemical classes with two or more chemicals across the combined dataset. The majority of these classes (105 chemical classes out of 142) contained chemicals from both datasets, whereas 8 classes contained only chemicals from the ELSIE dataset and 29 classes contain only chemicals from the PQRI dataset. This evaluation also identified classes containing chemicals that were flagged as potentially mutagenic as well as potent (strong or extreme) dermal sensitizers by in silico tools. The prevalence of alerting structures in the E&L datasets was approximately 9% (69 examples) for mutagens and 3% (25 examples) for potent sensitizers. This analysis showed that most (80%; 20/25) of E&L predicted to be strong or extreme dermal sensitizers were also flagged as potential mutagens. Only two chemical classes each containing three chemicals (alkyl bromides and isothiocyanates) were uniquely identified in the PQRI dataset and contained chemicals predicted to be potential mutagens and/or potent dermal sensitizers.
- 19 December 2023
- Published by Parenteral Drug Association, Inc. in PDA Journal of Pharmaceutical Science and Technology
- Vol. 78 (3) , 237-311
Characterizing Extractables and Leachables Chemical Space to Support In Silico Toxicological Hazard Assessments
This article describes the development of a representative dataset of extractables and leachables (E&L) from the combined Extractables and Leachable Safety Information Exchange (ELSIE) Consortium and the Product Quality Research Institute (PQRI) published datasets, representing a total of 783 chemicals. A chemical structure-based clustering of the combined dataset identified 142 distinct chemical classes with two or more chemicals across the combined dataset. The majority of these classes (105 chemical classes out of 142) contained chemicals from both datasets, whereas 8 classes contained only chemicals from the ELSIE dataset and 29 classes contain only chemicals from the PQRI dataset. This evaluation also identified classes containing chemicals that were flagged as potentially mutagenic as well as potent (strong or extreme) dermal sensitizers by in silico tools. The prevalence of alerting structures in the E&L datasets was approximately 9% (69 examples) for mutagens and 3% (25 examples) for potent sensitizers. This analysis showed that most (80%; 20/25) of E&L predicted to be strong or extreme dermal sensitizers were also flagged as potential mutagens. Only two chemical classes each containing three chemicals (alkyl bromides and isothiocyanates) were uniquely identified in the PQRI dataset and contained chemicals predicted to be potential mutagens and/or potent dermal sensitizers.